Articles
Page 7 of 34
-
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P43
-
A new AR therapy (MP29-02*): all of ARIA in one puff
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P42 -
Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P41 -
Deposition characteristics of a new allergic rhinitis nasal spray (MP29-02*) in an anatomical model of the human nasal cavity
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P40 -
Identification of gaps in the current allergic rhinitis guidelines and how these can be filled
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P39 -
A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity.
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P38 -
Real-life effectiveness of a new allergic rhinitis therapy (MP29-02*) in Sweden
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P37 -
MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P36 -
Adenoidal enlargements and associated disease in children
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P35 -
A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P34 -
A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P33 -
Patient reported outcome measurements in chronic rhinosinusitis; assessing the correlation between RSOM-31 and VAS.
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P28 -
Acute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P26 -
Heredity, symptoms and risk factors of nasal polyps
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P24 -
Pooideae molecular sensitization profile in selected rhinitis patients with allergy to grass pollen and maize-derived edible products
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P21 -
Proprotein convertase 5/6A is associated with bone morphogenetic protein-2-induced squamous cell differentiation
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P20 -
Immunologic responses to the major allergen of Olea Europaea in local and systemic allergic rhinitis subjects
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P19 -
Use of filter disks or sinus packs for single and repeated measurement of total IgE and house dust mite specific IgE in nasal secretions
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P18 -
The effect of MP29-02* is mediated via bitter taste receptors (TAS2R)
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P17 -
Analysis of mucociliar clearance: a new diagnostic method and a therapeutical proposal
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P16 -
Effect of histamine H3 receptor selective agonist imetit on cough and symptoms of allergic rhinitis in animal model of upper airway cough syndrome
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P13 -
Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O11 -
Relationship between the response to allergen, histamine and hypertonic saline nasal challenge and subjective reactivity to irritants in subjects with seasonal allergic rhinitis
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O10 -
MP29-02* reduces eosinophil survival induced by epithelial cell secretions from nasal mucosa
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P9 -
Uncontrolled chronic rhinosinusitis with and without polyps is predicted by T cell subtype
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O9 -
First experiences with cough sensitivity in model of allergic rhinitis induced in HDM-sensitized guinea pigs
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P8 -
Antigen presenting epithelial cells play a pivotal role in airway allergy
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O8 -
Converging evidence for the pro-inflammatory role of p-glycoprotein in Th2 polarized chronic rhinosinusitis endotypes
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P7 -
Genome wide gene expression analysis of nasal mucosa from patients with chronic rhinosinusitis and nasal polyposis stimulated with staphylococcal enterotoxin B
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O7 -
Endoscopic sinus surgery improve quality of life and decrease absenteeism in patients with chronic rhinosinusitis - a multi-centre study
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O6 -
Nasal citology: a new diagnostic approach in rhinology
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P5 -
Expression profiling of nasal polyp epithelial cells identifies two distinct phenotypes and suggests a role for neurogenic inflammation
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O5 -
Breaking nasal epithelial cell tolerance lipopolysaccharide exposure by CD16 mediated co-stimulation with human serum immunoglobulin G
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P4 -
Clinical changes induced by allergen immunotherapy with dermatophagoides pteronyssinus in local allergic rhinitis
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O4 -
TAS2R38 taste receptor gene and chronic rhinosinusitis: a bitter ending
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P3 -
Thymic Stromal Lymphopoietin (TSLP) promotes human eosinophil-basophil in situ hemopoieisis, and its secretion from human nasal epithelium is a function of TSLP genotype
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O3 -
Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215N
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P2 -
The ‘GA²LEN Sinusitis Cohort’: an introduction
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):O1 -
New insights into the pathogenesis of non-allergic rhinitis
Citation: Clinical and Translational Allergy 2015 5(Suppl 4):P1 -
Assessment of sensitization to grape and wine allergens as possible causes of adverse reactions to wine: a pilot study
In a recently performed survey with 4000 randomly selected persons, 68 (7.2 %) of 948 respondents reported intolerance and/or allergy-like symptoms to wine. The aim of this study was to analyze whether a real ...
Citation: Clinical and Translational Allergy 2015 5:21 -
Use of a basophil activation test as a complementary diagnostic tool in the diagnosis of severe peanut allergy in adults
Diagnosis of severe peanut allergy is difficult and delays in making an accurate diagnosis may place the patient at risk. Adults with a history of anaphylaxis must strictly avoid any contact with peanuts or pr...
Citation: Clinical and Translational Allergy 2015 5:22 -
Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs
With the aim of actively contributing to the ongoing 11th International Classification of Diseases (ICD) revision, an international collaboration led by the European Academy of Allergy and Clinical Immunology (EA...
Citation: Clinical and Translational Allergy 2015 5:20 -
Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
The 300IR (index of reactivity) 5-grass pollen tablet has favorable short-term and sustained clinical efficacy in patients with grass pollen-induced allergic rhinoconjunctivitis (ARC). Here, we report maintena...
Citation: Clinical and Translational Allergy 2015 5:12 -
Usefulness of open mixed nut challenges to exclude tree nut allergy in children
To minimize the risk of accidental reactions, atopic children with multiple sensitizations to tree nuts are advised to avoid all nuts. Multiple food challenges would be needed to confirm the clinical relevance...
Citation: Clinical and Translational Allergy 2015 5:19 -
“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
Allergen immunotherapy (AIT) is a guidelines-approved, disease-modifying treatment option for respiratory allergies, including allergic rhinitis (AR) induced by pollen. The various AIT regimens employed to dat...
Citation: Clinical and Translational Allergy 2015 5:18 -
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Adherence to allergen immunotherapy is important for its effectiveness. There is currently limited data available on allergen immunotherapy adherence outside of clinical trials i.e. in real-life clinical pract...
Citation: Clinical and Translational Allergy 2015 5:17 -
Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities
Both humans and their most important domestic animals harbor IgE and a similar IgE receptor repertoire and expression pattern. The same cell types are also involved in the triggering or regulation of allergie...
Citation: Clinical and Translational Allergy 2015 5:15 -
Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
We previously estimated that the annual rate of accidental exposure to peanut in 1411 children with peanut allergy, followed for 2227 patient-years, was 11.9% (95% CI, 10.6, 13.5). This cohort has increased to...
Citation: Clinical and Translational Allergy 2015 5:16 -
Maillard-type neoallergens present in processed soy extract may cause an allergic reaction in soy allergic patients
Citation: Clinical and Translational Allergy 2015 5(Suppl 3):P21 -
Risk assessment of peanut protein traces found in refined peanut oil
Citation: Clinical and Translational Allergy 2015 5(Suppl 3):O13